Page last updated: 2024-11-05

ticlopidine and Hematoma, Subdural, Acute

ticlopidine has been researched along with Hematoma, Subdural, Acute in 1 studies

Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.

Hematoma, Subdural, Acute: Accumulation of blood in the SUBDURAL SPACE with acute onset of neurological symptoms. Symptoms may include loss of consciousness, severe HEADACHE, and deteriorating mental status.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mascarenhas, L1

Other Studies

1 other study available for ticlopidine and Hematoma, Subdural, Acute

ArticleYear
Illustration of the impact of antiplatelet drugs on the genesis and management of chronic subdural hematoma.
    Neuro-Chirurgie, 2012, Volume: 58, Issue:1

    Topics: Aged; Aged, 80 and over; Aspirin; Cerebral Hemorrhage; Clopidogrel; Drug Therapy, Combination; Hemat

2012